Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 5/20 | 0.41 |
| ▸ | DPP8 | Q6V1X1 | 4/20 | 0.41 |
| ▸ | DPP9 | Q86TI2 | 4/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.41 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.38 |
| ▸ | GPR142 | Q7Z601 | 9/20 | 0.37 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.34 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.34 |
| ▸ | GPR88 | Q9GZN0 | 1/20 | 0.34 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.33 |
| ▸ | GRB2 | P62993 | 1/20 | 0.33 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1617776 | 0.91 | DPP4 (0.45) | DPP4DPP8DPP9OPRD1OPRL1 | |
| SCHEMBL1617758 | 0.91 | DPP4 (0.45) | DPP4DPP8DPP9OPRD1OPRL1 | |
| Hydrochloric Acid SCHEMBL6165352 | 0.89 | DPP4 (0.44) | DPP4DPP8DPP9OPRD1OPRL1 | |
| Hydrochloric Acid SCHEMBL6165347 | 0.89 | DPP4 (0.44) | DPP4DPP8DPP9OPRD1OPRL1 | |
| Trifluoroacetic Acid SCHEMBL5735676 | 0.85 | GRB2 (0.46) | DPP4DPP8DPP9OPRD1GPR142 | |
| Trifluoroacetic Acid SCHEMBL2495756 | 0.77 | GRB2 (0.33) | DPP4DPP8DPP9GRB2DPP7 | |
| SCHEMBL990478 | 0.76 | DPP4 (0.49) | DPP4DPP8DPP9OPRD1GPR142 | |
| SCHEMBL990477 | 0.76 | DPP4 (0.49) | DPP4DPP8DPP9OPRD1GPR142 | |
| SCHEMBL5907044 | 0.76 | DPP4 (0.49) | DPP4DPP8DPP9OPRD1GPR142 | |
| SCHEMBL5810527 | 0.75 | OPRL1 (0.41) | DPP4DPP8DPP9OPRD1OPRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8030499-B2 | 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2011-10-04 | — | — | US | disclosed |
| US-20080318923-A1 | 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2008-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080318923-A1 | 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle | AVPR1B, AVPR1A, AVPR2 | DPP4 2704/4885DPP8 2961/4885DPP9 3556/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.